Polyarteritis nodosa: Difference between revisions
(Text replacement - "*UA" to "*Urinalysis") |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Necrotizing vasculitis of small- and medium-sized blood vessels | *Necrotizing [[vasculitis]] of small- and medium-sized blood vessels | ||
*Skin, musculoskeletal, CNS, and GI tract (spares lung) | *Skin, musculoskeletal, CNS, and GI tract (spares lung) | ||
*Predilection to arterial bifurcations and branch sites | *Predilection to arterial bifurcations and branch sites | ||
| Line 11: | Line 11: | ||
*Men > women (2:1) | *Men > women (2:1) | ||
*Peak age 40-60s | *Peak age 40-60s | ||
*Systemic: Fatigue, weight loss, weakness, fever, arthralgia | *Systemic: Fatigue, weight loss, weakness, [[fever]], [[arthralgia]] | ||
*Cutaneous lesions (1/3 patients) | *Cutaneous lesions (1/3 patients) | ||
**Tender erythematous nodules | **Tender erythematous nodules | ||
**Palpable | **Palpable [[purpura]] (fingers, ankles, malleoli, pretibial) | ||
**Digital cyanosis | **Digital cyanosis | ||
**Splinter hemorrhages | **Splinter hemorrhages | ||
**Livedo reticularis | **Livedo reticularis | ||
*Renovascular arteritis → hypertension | *Renovascular arteritis → [[hypertension]] | ||
*Peripheral neuropathies (mononeuritis multiplex, polyneuropathy) | *Peripheral neuropathies (mononeuritis multiplex, polyneuropathy) | ||
*Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation) | *Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation) | ||
*Myocardial ischemia and heart failure | *[[Myocardial ischemia]] and [[heart failure]] | ||
*Myalgia (elevated CK) | *Myalgia (elevated CK) | ||
| Line 28: | Line 28: | ||
**Unexplained weight loss greater than 4kg | **Unexplained weight loss greater than 4kg | ||
**Livedo reticularis | **Livedo reticularis | ||
**Testicular | **[[Testicular Pain]] or tenderness | ||
**Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy | **Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy | ||
**Mononeuropathy or polyneuropathy | **Mononeuropathy or polyneuropathy | ||
| Line 54: | Line 54: | ||
*Embolism, thrombosis, atherosclerosis | *Embolism, thrombosis, atherosclerosis | ||
*[[HIV]], [[Hepatitis]], IE, mycotic aneurysm | *[[HIV]], [[Hepatitis]], IE, mycotic aneurysm | ||
*Fibromuscular | *Fibromuscular dysplasia | ||
*Microscopic polyangiitis, Granulomatosis with polyangiitis (Wegener's), | *Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis | ||
==Management== | ==Management== | ||
| Line 64: | Line 64: | ||
**[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening | **[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening | ||
*Immunosuppressive agent for moderate to severe | *Immunosuppressive agent for moderate to severe | ||
**Cyclophosphamide (600mg/m2<sup>) q2weeks x 3 doses | **[[Cyclophosphamide]] (600mg/m2<sup>) q2weeks x 3 doses | ||
*ACEI or ARB for hypertension | *[[ACEI]] or [[ARB]] for hypertension | ||
==References== | ==References== | ||
Revision as of 22:49, 13 November 2016
Background
- Necrotizing vasculitis of small- and medium-sized blood vessels
- Skin, musculoskeletal, CNS, and GI tract (spares lung)
- Predilection to arterial bifurcations and branch sites
- Microaneurysm, thrombosis, emboli, organic ischemia, and infarction
- Etiology: Idiopathic, HBV, HCV, hairy cell leukemia
Evaluation
Clinical Features
- Cutaneous lesion + adult onset hypertension
- Men > women (2:1)
- Peak age 40-60s
- Systemic: Fatigue, weight loss, weakness, fever, arthralgia
- Cutaneous lesions (1/3 patients)
- Tender erythematous nodules
- Palpable purpura (fingers, ankles, malleoli, pretibial)
- Digital cyanosis
- Splinter hemorrhages
- Livedo reticularis
- Renovascular arteritis → hypertension
- Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
- Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
- Myocardial ischemia and heart failure
- Myalgia (elevated CK)
Classification
- American College of Rheumatology 10 criteria (at least 3, has 82% sensitivity and 87% specificity)
- Unexplained weight loss greater than 4kg
- Livedo reticularis
- Testicular Pain or tenderness
- Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
- Mononeuropathy or polyneuropathy
- New-onset diastolic blood pressure > 90mmHg
- Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
- Evidence of HBV infection (serology)
- Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
- Biopsy of small- or medium-sized artery containing polymorphonuclear cells
Workup
- Definitive: Tissue biopsy
- Labs:
- Cr, CK, LFT (elevated)
- CBC (Leukocytosis, normochromic anemia, thrombocytosis)
- Hepatitis serology
- Urinalysis (proteinuria)
- ESR/CRP
- Imaging
- Angiography preferred: aneurysm or stenosis of medium-sized vessels
- Arteriograms
- CT/MRI
- To consider: CXR, blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases
Differential Diagnosis
- Embolism, thrombosis, atherosclerosis
- HIV, Hepatitis, IE, mycotic aneurysm
- Fibromuscular dysplasia
- Microscopic polyangiitis, Granulomatosis with polyangiitis (Wegener's), Eosinophilic granulomatosis with polyangiitis (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, connective tissue disease, SLE, cryoglobulinemic vasculitis
Management
- Rheumatology consult
- May warrant surgical intervention if abdominal involvement
- Corticosteroid:
- Prednisone 1mg/kg
- Methylprednisolone (7-15mg/kg, max 1000mg IV) for severe, organ threatening
- Immunosuppressive agent for moderate to severe
- Cyclophosphamide (600mg/m2) q2weeks x 3 doses
- ACEI or ARB for hypertension
References
- Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
- Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
- Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
- Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.
